Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.
Jay W. Marks, MD, is a board-certified internist and gastroenterologist. He graduated from Yale University School of Medicine and trained in internal medicine and gastroenterology at UCLA/Cedars-Sinai Medical Center in Los Angeles.
Combining interferon beta-1a with
may increase the risk of
bone marrow suppression with reduced blood cell counts.
PREGNANCY AND BREASTFEEDING SAFETY:
Use of interferon beta-1a has not been adequately evaluated in
women. Due to the lack of conclusive safety data, interferon beta-1a should be
used in pregnancy only if the potential benefit justifies the potential risk to
It is not known if interferon beta-1a is excreted in
breast milk. As many
drugs enter breast milk and can potentially cause harm to the nursing infant,
interferon beta-1a should be used cautiously in nursing mothers
Preferably interferon beta-1a should be stored refrigerated between
2 C to 8 C (36 F to 46 F).
If needed, interferon beta-1a powder can be stored at 25 C (77 F) for up to
30 days if a refrigerator is not available. It must be used within 6 hours if
refrigerated at 2 C to 8 C (36 F to 46 F) once the powder is diluted with
The autoinjector and prefilled syringe may be stored at 25 C (77 F) or lower
temperatures for 7 days if a refrigerator is not available. Once the
product is removed from the refrigerator, it must not be stored above 25 C